ORLANDO, Fla. -- The American Association for Cancer Research will recognize 27 recipients of the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students at the AACR 102nd Annual Meeting 2011, held here from April 2 to 6.
The primary purpose of the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students is to inspire science students at the undergraduate level to enter the field of cancer research.
The AACR is committed to promoting the education and training of the next generation of dedicated scientists, and to facilitating and nurturing their careers in cancer research or cancer-related biomedical science. Since its founding in 1997, AACR Science Education Awards have been supported by generous annual contributions from a distinguished member of the AACR, Dr. Thomas J. Bardos. His contributions are subsequently matched by those of AACR.
The recipients of the 2010-2011 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Krister J. Barkovich, University of California, Berkeley, Calif.
- Raul Caso, University of Miami, Coral Gables, Fla.
- Kevin Chen, The College of New Jersey, Trenton, N.J.
- Dustin L. Gable, The Ohio State University, Columbus, Ohio
- Daniel T. Huynh, University of the Pacific, Stockton, Calif.
- Orli Kadoch, University of California, Davis, Calif.
- Elizabeth J. Kennedy, University of Michigan, Ann Arbor, Mich.
Abstract #1397. The effects of mevalonate pathway inhibitors on the motility and invasion of aggressive breast cancers
- Alan Kiang, University of California San Diego, La Jolla, Calif.
- Natalie A. Vandeven, University of Michigan, Ann Arbor, Mich.
- Chaoying Sarah Xu, University of Toronto, Toronto, Ontario
The recipients of the 2011-2012 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Jeff Chen, University of California Davis, Davis, Calif.
- Benjamin W. Dulken, University of Washington, Seattle, Wash.
- Aurian P. Garcia-Gonzalez, University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico
Abstract #3200. HPV status influences the survival of HNSCC patients: A consideration for the TNM staging system
- Allison Gomez, University of California San Diego, San Diego, Calif.
- Kelsey Gray, Ohio State University, Columbus, Ohio
- Akash Gupta, University of Louisville, Louisville, Ky.
- Nisan M. Hubbard, Virginia Commonwealth University, Richmond, Va.
- Thomas M. Kaffenberger, Ohio State University Medical Center, Columbus, Ohio
- Steve L. Lu, The University of Texas MD Anderson Cancer Center, Austin, Texas
- Ashwathi S. Mohan, Texas A&M University College of Science, College Station, Texas
- Melony A. Ochieng, North Carolina Central University, Durham, N.C.
- Emily E. Ortega, Johns Hopkins University, Baltimore, Md.
- Daniel W. Sharp, Brigham Young University, Provo, Utah
Abstract #3162. Assessing the therapeutic and diagnostic potential of human thymidine kinase 1 in leukemia
Abstract #1678. Visualization of thymidine kinase 1 on the surface of cancer cell lines: A potential diagnostic marker and therapeutic target
- Daniel C. Sotelo, University of Arizona Cancer Center, Tucson, Ariz.
- Ken Tanaka, Amherst College, Amherst, Mass.
- Christopher A. Walker, University of Georgia, Athens, Ga.
- Lian Zhu, University of Michigan Comprehensive Cancer Center, Ann Arbor, Mich.
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.